Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
US Department of Justice
Teva
Accenture
McKesson
Cerilliant
Dow
Boehringer Ingelheim
UBS
Argus Health

Generated: February 23, 2018

DrugPatentWatch Database Preview

CYCLOBENZAPRINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Cyclobenzaprine Hydrochloride patents expire, and what generic alternatives are available?

Cyclobenzaprine Hydrochloride is a drug marketed by Twi Pharms Inc, Actavis Labs Fl Inc, Aurobindo Pharma, Frontida Biopharm, Invagen Pharms, Jubilant Cadista, Kvk Tech, Mylan Pharms Inc, Orit Labs Llc, Oxford Pharms, Pliva, Prinston Inc, Rubicon Res Pvt Ltd, Sandoz, Sun Pharm Inds Ltd, Upsher-smith Labs, and Watson Labs. and is included in eighteen NDAs.

The generic ingredient in CYCLOBENZAPRINE HYDROCHLORIDE is cyclobenzaprine hydrochloride. There are fifteen drug master file entries for this compound. Eighty suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the cyclobenzaprine hydrochloride profile page.
Drug patent expirations by year for CYCLOBENZAPRINE HYDROCHLORIDE
Pharmacology for CYCLOBENZAPRINE HYDROCHLORIDE

US Patents and Regulatory Information for CYCLOBENZAPRINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd CYCLOBENZAPRINE HYDROCHLORIDE cyclobenzaprine hydrochloride TABLET;ORAL 078722-002 May 12, 2008 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Rubicon Res Pvt Ltd CYCLOBENZAPRINE HYDROCHLORIDE cyclobenzaprine hydrochloride TABLET;ORAL 208170-002 May 31, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Inds Ltd CYCLOBENZAPRINE HYDROCHLORIDE cyclobenzaprine hydrochloride TABLET;ORAL 078722-003 May 12, 2008 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Rubicon Res Pvt Ltd CYCLOBENZAPRINE HYDROCHLORIDE cyclobenzaprine hydrochloride TABLET;ORAL 208170-003 May 31, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Twi Pharms Inc CYCLOBENZAPRINE HYDROCHLORIDE cyclobenzaprine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 091281-001 Jan 31, 2013 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc CYCLOBENZAPRINE HYDROCHLORIDE cyclobenzaprine hydrochloride TABLET;ORAL 073144-003 Mar 25, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pliva CYCLOBENZAPRINE HYDROCHLORIDE cyclobenzaprine hydrochloride TABLET;ORAL 074421-001 Sep 29, 1995 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma CYCLOBENZAPRINE HYDROCHLORIDE cyclobenzaprine hydrochloride TABLET;ORAL 078643-002 Sep 26, 2008 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs CYCLOBENZAPRINE HYDROCHLORIDE cyclobenzaprine hydrochloride TABLET;ORAL 073143-001 Nov 27, 1991 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Labs Fl Inc CYCLOBENZAPRINE HYDROCHLORIDE cyclobenzaprine hydrochloride TABLET;ORAL 071611-003 Feb 3, 2006 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
McKesson
Cipla
Boehringer Ingelheim
Farmers Insurance
Harvard Business School
Johnson and Johnson
Chinese Patent Office
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot